Back
Capricor Therapeutics Stock Price Chart

One Tool. Personalized Setups.
Try it here.
Sell
47
CAPR
Capricor Therapeutics
Last Price:
$10.21
Seasonality Move:
29.2%
7 Day Trial
ALL ACCESS PASS
$
7

Slow Market? Try This Instead
See how it works now.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing slight selling pressure.
Capricor Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.07 | Buy |
20-day SMA: | 11.33 | Sell |
50-day SMA: | 10.72 | Sell |
200-day SMA: | 13.46 | Sell |
8-day EMA: | 10.18 | Buy |
20-day EMA: | 10.59 | Sell |
50-day EMA: | 10.9 | Sell |
200-day EMA: | 11.36 | Sell |
Capricor Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.32 | Sell |
Relative Strength Index (14 RSI): | 47.85 | Sell |
Chaikin Money Flow: | -303353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.44 - 12.98) | Sell |
Bollinger Bands (100): | (9.31 - 13.93) | Sell |
Capricor Therapeutics Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Capricor Therapeutics Stock
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 10.25 while CAPR 8-day simple moving average is 10.07, which is a Buy signal.
-
The stock price of CAPR is 10.25 while Capricor Therapeutics 20-day SMA is 11.33, which makes it a Sell.
-
Capricor Therapeutics 50-day simple moving average is 10.72 while CAPR share price is 10.25, making it a Sell technically.
-
CAPR stock price is 10.25 and Capricor Therapeutics 200-day simple moving average is 13.46, creating a Sell signal.
CAPR Technical Analysis vs Fundamental Analysis
Sell
47
Capricor Therapeutics (CAPR)
is a Sell
Is Capricor Therapeutics a Buy or a Sell?
-
Capricor Therapeutics stock is rated a SellThe current Capricor Therapeutics [CAPR] share price is $10.25. The Score for CAPR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Capricor Therapeutics Stock Info
Market Cap:
468.5M
Price in USD:
10.25
Share Volume:
755.6K
Capricor Therapeutics 52-Week Range
52-Week High:
23.40
52-Week Low:
3.52
Sell
47
Capricor Therapeutics (CAPR)
is a Sell
Capricor Therapeutics Share Price Forecast
-
What is the Capricor Therapeutics stock price today?The Capricor Therapeutics stock price is 10.25 USD today.
-
Will CAPR stock go up or go down?Capricor Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Capricor Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Capricor Therapeutics is overvalued.
Is Capricor Therapeutics Stock a Buy?
-
Capricor Therapeutics share price is 10.25 while CAPR 8-day exponential moving average is 10.18, which is a Buy signal.
-
The stock price of CAPR is 10.25 while Capricor Therapeutics 20-day EMA is 10.59, which makes it a Sell.
-
Capricor Therapeutics 50-day exponential moving average is 10.90 while CAPR share price is 10.25, making it a Sell technically.
-
CAPR stock price is 10.25 and Capricor Therapeutics 200-day simple moving average is 11.36, creating a Sell signal.
Fundamental Analysis of Capricor Therapeutics
Is Capricor Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.51 per share, an increase this year of $1.41 per share, and a decrease next year of $0.76 per share.
Technical Analysis of Capricor Therapeutics
Should I short Capricor Therapeutics stock?
-
CAPR Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Capricor Therapeutics is a Sell
-
Capricor Therapeutics Relative Strength Index (RSI) is 47.85, which suggest Capricor Therapeutics is oversold
-
The Bollinger Bands (25) for Capricor Therapeutics is (9.44 - 12.98), which suggest Capricor Therapeutics is a Sell
-
The Bollinger Bands (100) for Capricor Therapeutics is (9.31 - 13.93), which suggest Capricor Therapeutics is a Sell
* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.